1887

Abstract

Previous studies have shown that the human papillomavirus type 16 (HPV-16) E6 protein binds to p300/CBP and abrogates its transcriptional co-activator function. However, there is little information on the biological consequences of this interaction and discrepancy as to whether the interaction is high-risk E6 specific or not. We performed a series of studies to compare the interactions of HPV-18 and HPV-11 E6 with p300, and showed that both high- and low- risk E6 proteins bind p300. In addition, using a transformation-deficient mutant of adenovirus E1a, which cannot interact with p300, we demonstrated that HPV-16, HPV-18 and, to a lesser extent, HPV-11 E6, can complement this mutant in cell transformation assays. In contrast, a mutant of HPV-16 E6 which does not bind p300 failed to rescue the E1a mutant. These results suggest that the E6–p300 interaction may be important for the ability of HPV E6 to contribute towards cell transformation.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-4-829
2002-04-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/4/0830829a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-4-829&mimeType=html&fmt=ahah

References

  1. Androphy, E., Hubbert, N., Schiller, J. & Lowy, D. ( 1987; ). Identification of the HPV-16 E6 protein from transformed cells and human cervical carcinoma cells. EMBO Journal 6, 989-992.
    [Google Scholar]
  2. Banks, L., Spence, P., Androphy, E., Hubbert, N., Matlashewski, G., Murray, A. & Crawford, L. ( 1987; ). Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. Journal of General Virology 68, 1351-1359.[CrossRef]
    [Google Scholar]
  3. Barbosa, M. S. & Schlegel, R. ( 1989; ). The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4, 1529-1532.
    [Google Scholar]
  4. Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B. & Livingston, D. M. ( 1994; ). Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes & Development 8, 869-884.[CrossRef]
    [Google Scholar]
  5. Eckner, R., Ludlow, J. W., Lill, N. L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J. A., Livingston, D. M. & Morgan, J. A. ( 1996; ). Association of p300 and CBP with simian virus 40 large T antigen. Molecular and Cellular Biology 16, 3454-3464.
    [Google Scholar]
  6. Foster, S. A., Demers, G. W., Etscheid, B. G. & Galloway, D. A. ( 1994; ). The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. Journal of Virology 68, 5698-5705.
    [Google Scholar]
  7. Gardiol, D., Kühne, C., Glaunsinger, B., Lee, S. S., Javier, R. & Banks, L. ( 1999; ). Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18, 5487-5496.[CrossRef]
    [Google Scholar]
  8. Hawley-Nelson, P., Vousden, K., Hubbert, N., Lowy, D. & Schiller, J. ( 1989; ). HPV-16 E6 and E7 proteins cooperate to immortalise human foreskin keratinocytes. EMBO Journal 8, 3905-3910.
    [Google Scholar]
  9. Hottiger, M. O. & Nabel, G. J. ( 1998; ). Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. Journal of Virology 72, 8252-8256.
    [Google Scholar]
  10. Huibregtse, J., Scheffner, M. & Howley, P. ( 1991; ). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO Journal 10, 4129-4135.
    [Google Scholar]
  11. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L. & Cho, K. R. ( 1993; ). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proceedings of the National Academy of Sciences, USA 90, 3988-3992.[CrossRef]
    [Google Scholar]
  12. Korzus, E., Torchia, J., Rose, D. W., Xu, L., Kurokawa, R., McInerney, E. M., Mullen, T.-M., Glass, C. K. & Rosenfeld, M. G. ( 1998; ). Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279, 703-707.[CrossRef]
    [Google Scholar]
  13. Kurokawa, R., Kalafus, D., Ogliastro, M.-H., Kioussi, C., Xu, L., Torchia, J., Rosenfeld, M. G. & Glass, C. K. ( 1998; ). Differential use of CREB binding protein-coactivator complexes. Science 279, 700-703.[CrossRef]
    [Google Scholar]
  14. Lane, D. ( 1992; ). P53: guardian of the genome. Nature 358, 15-16.[CrossRef]
    [Google Scholar]
  15. Massimi, P., Pim, D., Storey, A. & Banks, L. ( 1996; ). HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12, 2325-2330.
    [Google Scholar]
  16. Patel, D., Huang, S.-M., Baglia, L. A. & McCance, D. ( 1999; ). The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO Journal 18, 5061-5072.[CrossRef]
    [Google Scholar]
  17. Pim, D., Storey, A., Thomas, M., Massimi, P. & Banks, L. ( 1994; ). Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Oncogene 9, 1869-1876.
    [Google Scholar]
  18. Pim, D., Thomas, M. & Banks, L. ( 2001; ). The function of the human papillomavirus oncogenes. In Viruses, Cell Transformation and Cancer , pp. 145-192. Edited by R. J. A. Grand. Amsterdam:Elsevier Science.
  19. Scheffner, M., Werness, B., Huibregtse, J., Levine, A. & Howley, P. ( 1990; ). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.[CrossRef]
    [Google Scholar]
  20. Schwarz, E., Freese, U., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. & zur Hausen, H. ( 1985; ). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.[CrossRef]
    [Google Scholar]
  21. Smith, D. H. & Ziff, E. B. ( 1988; ). The amino-terminal region of the adenovirus serotype 5 E1a protein performs two separate functions when expressed in primary baby rat kidney cells. Molecular and Cellular Biology 8, 3882-3890.
    [Google Scholar]
  22. Stein, R. W., Corrigan, M., Yaciuk, P., Whelan, J. & Moran, E. ( 1990; ). Analysis of E1A-mediated growth regulation functions: binding of 300 kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. Journal of Virology 64, 4421-4427.
    [Google Scholar]
  23. Storey, A., Pim, D., Murray, A., Osborn, K., Banks, L. & Crawford, L. ( 1988; ). Comparison of the in vitro transforming activities of human papillomavirus types. EMBO Journal 7, 1815-1820.
    [Google Scholar]
  24. Werness, B., Levine, A. & Howley, P. ( 1990; ). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.[CrossRef]
    [Google Scholar]
  25. Whyte, P., Ruley, H. E. & Harlow, E. ( 1988; ). Two regions of the adenovirus early region 1A proteins are required for transformation. Journal of Virology 62, 257-265.
    [Google Scholar]
  26. Wu, X. & Levine, A. ( 1994; ). p53 and E2-F cooperate to mediate apoptosis. Proceedings of the National Academy of Sciences, USA 91, 3602-3606.[CrossRef]
    [Google Scholar]
  27. Zimmermann, H., Degenkolbe, R., Bernard, H.-U. & O’Connor, M. J. ( 1999; ). The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. Journal of Virology 73, 6209-6219.
    [Google Scholar]
  28. Zimmermann, H., Koh, C.-H., Degenkolbe, R., O’Connor, M. J., Muller, A., Steger, G., Chen, J. J., Liu, Y., Androphy, E. & Bernard, H.-U. ( 2000; ). Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. Journal of General Virology 81, 2617-2623.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-4-829
Loading
/content/journal/jgv/10.1099/0022-1317-83-4-829
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error